|
SLC9A7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.12340003544898E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.1512999987271E-09 |
| Normal-vs-Stage2 |
2.383000E-04 |
| Normal-vs-Stage3 |
5.64629998311972E-09 |
| Normal-vs-Stage4 |
2.374200E-04 |
| Stage1-vs-Stage2 |
8.884200E-01 |
| Stage1-vs-Stage3 |
1.234160E-01 |
| Stage1-vs-Stage4 |
7.447000E-01 |
| Stage2-vs-Stage3 |
4.900400E-01 |
| Stage2-vs-Stage4 |
8.911800E-01 |
| Stage3-vs-Stage4 |
6.185000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84030002348123E-09 |
| Normal-vs-AfricanAmerican |
8.216100E-03 |
| Normal-vs-Asian |
2.584200E-01 |
| Caucasian-vs-AfricanAmerican |
2.152200E-01 |
| Caucasian-vs-Asian |
3.010200E-01 |
| AfricanAmerican-vs-Asian |
7.416200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.12110000008536E-07 |
| Normal-vs-Female |
1.93789995162064E-09 |
| Male-vs-Female |
8.064000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.605400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.54549999973075E-07 |
| Normal-vs-Age(61-80Yrs) |
1.4026000028089E-08 |
| Normal-vs-Age(81-100Yrs) |
1.802210E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.309400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.597400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.330600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.109400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.343800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.518800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.793600E-02 |
| Normal-vs-Grade 2 |
3.60880003658082E-09 |
| Normal-vs-Grade 3 |
1.03330000111868E-09 |
| Normal-vs-Grade 4 |
1.195930E-03 |
| Grade 1-vs-Grade 2 |
2.952600E-01 |
| Grade 1-vs-Grade 3 |
2.360600E-01 |
| Grade 1-vs-Grade 4 |
4.752400E-01 |
| Grade 2-vs-Grade 3 |
7.236600E-01 |
| Grade 2-vs-Grade 4 |
7.571800E-01 |
| Grade 3-vs-Grade 4 |
6.359600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.26790039473224E-10 |
| Normal-vs-ccB subtype |
9.586200E-04 |
| ccA subtype-vs-ccB subtype |
1.577560E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.19010000030084E-08 |
| Normal-vs-N1 |
4.344100E-02 |
| N0-vs-N1 |
4.929200E-01 |
|
|
